Citation Impact
Citing Papers
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
2018
New clinical trials for nonmotor manifestations of Parkinson's disease
2015
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Cognitive decline in Parkinson disease
2017
Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
2013
Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
2017
Parkinson disease
2017 Standout
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Changes in Lipidome Composition during Brain Development in Humans, Chimpanzees, and Macaque Monkeys
2017 StandoutNobel
Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
2018
Genetic modification of the association of paraquat and Parkinson's disease
2012
Neurochemistry and the non-motor aspects of PD
2011
Ageing as a risk factor for neurodegenerative disease
2019 Standout
The association between infectious burden and Parkinson's disease: A case-control study
2015
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
2014 Standout
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
2011
Substitution p.A350V in Na+/Mg2+ Exchanger SLC41A1, Potentially Associated with Parkinson's Disease, Is a Gain-of-Function Mutation
2013
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
2019
Parkinson's disease in the Western Pacific Region
2019
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
2010
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Differentiating Parkinson’s disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test
2011
Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
2013
Gut microbiota: Implications in Parkinson's disease
2017
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis
2011
Metabolic markers or conditions preceding Parkinson's disease: A case‐control study
2012
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
2015
Myasthenia gravis
2019 Standout
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
2018
Potential Cardiac Valve Effects of Dopamine Agonists in Hyperprolactinemia
2010
Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
2018
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Non-motor features of Parkinson disease
2017 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Parkinson's disease research in a prospective cohort in China
2015
The Risk of Parkinson Disease Associated with Urate in a Community-Based Cohort of Older Adults
2011
GBA1-associated parkinsonism: new insights and therapeutic opportunities
2019
Antioxidants and human diseases
2014
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Targeting metabolic inflammation in Parkinson’s disease: Implications for prospective therapeutic strategies
2011
Vitamin A and Carotenoids and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
2013
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
2015
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
2016
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
De novo design of a homo-trimeric amantadine-binding protein
2019 StandoutNobel
Assessing mitochondrial dysfunction in cells
2011 Standout
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
2018 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Rituximab treatment of myasthenia gravis: A systematic review
2017
Diabetes and Risk of Parkinson’s Disease
2011
Dietary fat intake and risk for Parkinson's disease
2014
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological Treatment of Parkinson Disease
2014
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases
2018
Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study
2015
Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
2014
Diabetes and the Risk of Developing Parkinson’s Disease in Denmark
2011
Pharmaceuticals that contain polycyclic hydrocarbon scaffolds
2015
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Fatty Acid Composition of the Anterior Cingulate Cortex Indicates a High Susceptibility to Lipid Peroxidation in Parkinson's Disease
2015
Intake of antioxidant vitamins and risk of Parkinson's disease
2016
Update of the MDS research criteria for prodromal Parkinson's disease
2019
Works of Tomoko Oeda being referenced
Dietary intake of metals and risk of Parkinson's disease: A case-control study in Japan
2011
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease
2008
Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
2015
Dietary glycemic index is inversely associated with the risk of Parkinson's disease: A case–control study in Japan
2009
Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP)
2013
Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson’s disease: A case-control study in Japan
2010
Dietary intake of antioxidant vitamins and risk of Parkinson’s disease: a case–control study in Japan
2010
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
2008
Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan
2009
Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease
2015
Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
2010
Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson's disease: a case–control study in Japan
2010
Dietary patterns and risk of Parkinson’s disease: a case–control study in Japan
2011
Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study
2013
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
2015
Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease
2011
Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan
2010
LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: A case–control study in Japan
2010
Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
2010
GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population
2010
Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson’s Disease: Case–control Study
2014
Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease
2018
A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab
2015